For instance, metformin modulates the synergistic regulation between AMPK, GSK-3β, and PPAR-γ that confer its anti-angiogenic, anti-invasive, and anti-proliferative as observed in pancreatic cancer and glioblastoma multiforme (GBM) [29]. This evidence concerns the gene GSK3B and glioblastoma.